semaglutide chronic kidney disease Ozempic picks up FDA indication to treat Ozempic Approved for Diabetic Kidney

Hypoglycemia was reported in 3.4% of all GLP1 exposures reported to one poison center, and patients should be counseled on signs and symptoms of hypoglycemia if being monitored at home

Losing a substantial amount of weight, especially quickly, can create challenges that diet and exercise alone can't fix

Common adverse effects include paraesthesia or tingling (2025% of users), dry mouth (20%), constipation (1517%), altered taste, insomnia, and cognitive difficulties with concentration and memory

This does not mean the product has no effect

Empagliflozin is used to reduce cardiovascular death risk in adults with type 2 diabetes and established cardiovascular disease